OpenVSafe by OpenVAERS
Search V-safe

5A7-51896-83141

2 vaccinations 13 coded responses 26 check-ins 12 free-text entries 2 call cases
Sex
Male
Age at first dose
66+
ZIP prefix
329 / FL
Registered
2021-03-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-12
    Dose 1 — Moderna
  2. 2021-03-14
    Registered in v-safe
  3. 2021-03-14
    Survey response — days 1–6 daily, dose 1
    MedDRA: Feeling abnormal — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Felt foggy mentally
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-15
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good · Site: Pain, Swelling
    Free text: No
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-16
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-03-17
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-19
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-26
    Survey response — day 14, dose 1
    MedDRA: Immunisation reaction, Malaise, Mobility decreased, Petechiae, Pruritus — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Began with itch day 8, and general malaise. Day 9 had COVID arm. Day 10 had PETECHIAE lower extremities. Day 12 was first sign of slight improvement, but noted increased PETECHIAE, and felt physically restricted.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-02
    Health check-in — day 21, dose 1
    Feeling: Fair
    Adult check-in
  10. 2021-04-09
    Survey response — day 28, dose 1
    MedDRA: Migraine, Telemedicine, Vertigo — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Began with Vertigo Two days ago. Experienced two episodes of migraine headaches within one week. · Healthcare visit (other): In office visit with my Internest.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-04-09
    Report sent to call center — day 28, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-04-16
    Survey response — day 35, dose 1
    MedDRA: Extrasystoles, Fatigue, Nervousness, Vertigo — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Nerves are more on edge. Noticed increase in ectopic heart beats at times. Easy fatigability. Mild vertigo with movement.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-04-23
    Health check-in — day 42, dose 1
    Feeling: Fair
    Adult check-in
  14. 2021-06-11
    Health check-in — 3 months, dose 1
    Feeling: Good
    Adult check-in
  15. 2021-09-10
    Survey response — 6 months, dose 1
    MedDRA: Balance disorder, Cognitive disorder — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Mild cognitive change and unsteadiness on ambulatory.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-03-12
    Health check-in — 12 months, dose 1
    Feeling: Good
    Adult check-in
  17. 2022-03-24
  18. 2022-09-28
    Dose 2 — Novavax
  19. 2022-09-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Site: Pain, Redness
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-09-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  21. 2022-10-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good · Site: Pain, Redness, Swelling
    Free text: No
    MedDRA releases: 2024-11 · check-in free text available
  22. 2022-10-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cutaneous vasculitis — Feeling: Good
    Free text: No, I'm currently making careful observations until I have passed at least 10 days post vaccination since I experienced a cutaneous small vessel vasculitis after one Moderna vaccine.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-10-04
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: No, only waiting for the 10 days post vaccine to pass uneventfully.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-10-05
    Survey response — day 7, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: No, just observing until 10 days post vaccine for any adverse reactions. October 8th will be 10 days.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-10-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-10-19
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  27. 2022-10-26
    Survey response — day 28, dose 2
    MedDRA: Erythema, Pain, Swelling — Feeling: Good · Be unable to work or attend school
    Free text: I received my second Novavax vaccine on 10/21/22. I had moderate swelling, erythema, and soreness after 2 days that has since resolved. In fact, I had a Flu shot on 10/24/22 with similar symptoms, but they were only mild.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-11-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  29. 2022-11-09
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  30. 2022-12-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2023-03-29
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia, Back pain, Musculoskeletal stiffness, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  32. 2023-03-29
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  33. 2023-03-30
  34. 2023-03-30
  35. 2023-03-30
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  36. 2023-03-30
    Call successful
    Not applicable - Accidental Reporting

Vaccinations

DoseDateManufacturerCo-administered
12021-03-12Moderna
22022-09-28Novavax No

Call center

ReportedOutcomeVAERS-related outcome
2021-04-09 Successful
2023-03-30
Reported to VAERS voluntarily prior to GDIT contact
2023-03-29 Successful
2023-03-30
Not applicable - Accidental Reporting

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-14

Systemic reaction (other): Felt foggy mentally

2021-03-15

Systemic reaction (other): No

Release 6 — day 14, dose 1

2021-03-26

Symptoms: Began with itch day 8, and general malaise. Day 9 had COVID arm. Day 10 had PETECHIAE lower extremities. Day 12 was first sign of slight improvement, but noted increased PETECHIAE, and felt physically restricted.

Release 7 — day 28, dose 1

2021-04-09

Symptoms: Began with Vertigo Two days ago. Experienced two episodes of migraine headaches within one week.
Healthcare visit (other): In office visit with my Internest.

Release 7 — day 35, dose 1

2021-04-16

Symptoms: Nerves are more on edge. Noticed increase in ectopic heart beats at times. Easy fatigability. Mild vertigo with movement.

Release 9 — 6 months, dose 1

2021-09-10

Symptoms: Mild cognitive change and unsteadiness on ambulatory.

Release 12 — days 1–6 daily, dose 2

2022-09-29

Systemic reaction (other): No

2022-10-01

Systemic reaction (other): No

2022-10-03

Systemic reaction (other): No, I'm currently making careful observations until I have passed at least 10 days post vaccination since I experienced a cutaneous small vessel vasculitis after one Moderna vaccine.

2022-10-04

Systemic reaction (other): No, only waiting for the 10 days post vaccine to pass uneventfully.

Release 12 — day 7, dose 2

2022-10-05

Systemic reaction (other): No, just observing until 10 days post vaccine for any adverse reactions. October 8th will be 10 days.

Release 12 — day 28, dose 2

2022-10-26

Symptoms: I received my second Novavax vaccine on 10/21/22. I had moderate swelling, erythema, and soreness after 2 days that has since resolved. In fact, I had a Flu shot on 10/24/22 with similar symptoms, but they were only mild.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
HCVOTelemedicine ✓ ✓ ✓
SDArthralgia · · ✓
SDBack pain · · ✓
SDBalance disorder · · ✓
SDCognitive disorder · · ✓
SDErythema · · ✓
SDExtrasystoles ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDImmunisation reaction ✓ ✓ ✓
SDMalaise ✓ ✓ ✓
SDMigraine ✓ ✓ ✓
SDMobility decreased ✓ ✓ ✓
SDMusculoskeletal stiffness · · ✓
SDNervousness ✓ ✓ ✓
SDPain · · ✓
SDPetechiae ✓ ✓ ✓
SDPruritus ✓ ✓ ✓
SDSwelling · · ✓
SDVertigo ✓ ✓ ✓
SROCutaneous vasculitis · · ✓
SROFeeling abnormal ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release